What Menopause Does to Cholesterol—and Why Your Standard Lipid Panel May Not Tell the Whole Story

Have you ever been told your cholesterol is “fine” even though something about your health feels different?

Maybe you’re in your 40s or 50s and suddenly you’re dealing with things you didn’t have before:

Trouble sleeping.
Weight that’s harder to manage.
Brain fog.
Changes in your menstrual cycle.
Hot flashes or night sweats.
Low energy.
Feeling exhausted in the morning but wired at night.

And then your annual bloodwork comes back. Maybe your cholesterol is a little higher than it used to be. Or maybe you’re told everything looks “normal.” But here’s something many women don’t realize:

The menopause transition can change your cholesterol picture.

And the four numbers on a standard cholesterol panel may not tell the entire story.

Here’s how I like to explain cholesterol to my patients. Cholesterol and triglycerides are fats. They can’t simply float freely through your bloodstream, so your body packages them into particles called lipoproteins that transport them around your body.

Think of your bloodstream like a harbor. The lipoprotein particles are the boats. The cholesterol and triglycerides are the cargo inside the boats.

Your standard cholesterol panel gives us useful information about that cargo. But sometimes I also want to know: How many boats are actually in the harbor?

That’s where ApoB becomes important. LDL-C Measures Cargo. ApoB Helps Count the Boats.

LDL cholesterol—or LDL-C—measures the amount of cholesterol being carried within LDL particles.

Think of it as measuring the cargo. ApoB tells us something different. Each major atherogenic lipoprotein particle carries one ApoB molecule. So measuring ApoB gives us a useful estimate of the number of atherogenic particles—or boats—circulating in the blood.

Why does that distinction matter? Imagine two harbors. One harbor has a few large boats carrying lots of cargo. The other has many smaller boats carrying the same total amount of cargo. The amount of cargo could be similar. But the number of boats is very different.

That’s why two people can have similar LDL-C levels but different ApoB levels.

And when it comes to atherosclerosis, particle number matters because ApoB-containing particles can enter and become retained within the artery wall. More boats in the harbor means more opportunities for a boat to end up where it doesn’t belong.

So What Does Menopause Have to Do With the Boats?

This is where the story gets especially interesting for women. Research following women through the menopause transition has found changes in cardiovascular risk factors around the final menstrual period, including increases in total cholesterol, LDL-C and ApoB.

In other words:

The number of boats can change during the menopause transition.

One reason may involve estrogen and the liver.

Your liver has LDL receptors that help remove LDL particles from circulation. Estrogen influences lipid metabolism and LDL-receptor activity. As estrogen changes during menopause, LDL clearance can change as well. The result can be more ApoB-containing particles remaining in circulation.

So when a woman tells me:

“I’ve eaten the same way for years. Why is my cholesterol suddenly going up?”

I don’t automatically assume she’s doing something wrong.

Her changing hormonal environment may be one part of the picture. That’s why I don’t want to look at cholesterol without also considering where she is hormonally and metabolically.

When There Are Too Many Boats. The artery wall isn’t just a passive pipe.

ApoB-containing particles can cross into and become retained within the artery wall. Once retained, they can undergo changes that contribute to inflammation and the development of atherosclerotic plaque.

Think of it as a crowded harbor.

The more atherogenic boats circulating, the greater the opportunity for particles to get into the artery wall. Over years, that matters.

This is why I don’t want to ask only:

“Is your cholesterol high?”

I want to ask:

“What kind of particles are circulating, how many are there, and what is the environment they’re circulating in?”

Then There’s One Very Different Boat: Lp(a)

Lp(a), or lipoprotein(a), is an ApoB-containing lipoprotein with an additional protein called apolipoprotein(a) attached to it.

If we’re staying with our harbor analogy, imagine an LDL-like boat with something extra attached to it.

And here’s what makes Lp(a) especially important:

Your Lp(a) level is largely determined by genetics.

Unlike ApoB and many metabolic markers, Lp(a) generally isn’t something that dramatically rises simply because you’ve entered menopause.

You were largely born with your tendency toward a certain Lp(a) level.

So here’s the simplest way to remember the difference:

Menopause may change the number of boats.

Lp(a) is a special kind of boat largely determined by your genetics.

That’s why I like knowing both numbers.

Why Test Lp(a) If It’s Genetic?

Because knowing about risk gives us context.

Elevated Lp(a) is associated with increased risk of atherosclerotic cardiovascular disease and aortic valve disease.

And many people have never had it checked.

You can exercise.

You can eat well.

You can maintain a healthy weight.

And you can still have elevated Lp(a).

That’s because this isn’t simply a lifestyle marker.

And because Lp(a) is largely inherited, finding an elevated level may also be useful information for close family members to discuss with their healthcare providers.

The Harbor Is Bigger Than Cholesterol

This is where my approach goes beyond simply ordering ApoB and Lp(a).

Because I don’t think cardiovascular health should be evaluated by one number. I want to know what’s happening throughout the harbor.

What’s your:

ApoB?
Lp(a)?
LDL-C?
HDL-C?
Triglycerides?
Blood pressure?
Fasting glucose?
Fasting insulin?
HbA1c?
Inflammation?
Thyroid function?
Nutrient status?

And for a woman in her 40s or 50s: What’s happening hormonally?

Because insulin resistance, elevated triglycerides, inflammation, blood pressure, smoking, genetics and other factors can all affect cardiovascular risk.

And Remember—Cholesterol Isn’t the Enemy

There’s another reason I don’t like reducing this conversation to “cholesterol is bad.”

Your body needs cholesterol.

Cholesterol is an essential component of cell membranes and is used to make steroid hormones including:

Estrogen
Progesterone
Testosterone
Cortisol

So I’m not interested in looking at one cholesterol number and deciding whether it’s simply “good” or “bad.”

I want to understand the entire picture.

THIS IS WHY I TEST

At AlphaCare Health, functional medicine testing allows me to look deeper than a basic annual panel.

Your standard cholesterol panel—total cholesterol, LDL-C, HDL-C and triglycerides—is important.

But sometimes it doesn’t answer all of my questions.

That’s why I may also look at ApoB and Lp(a).

And then I connect those findings with blood sugar, insulin, thyroid function, nutrients, inflammation and hormones.

Because when you’re tired, gaining weight, bloated, waking up at 3 a.m., noticing your hair falling out or simply thinking:

“I don’t feel like myself anymore.”

I don’t want to look at one isolated number.

I want to understand how the pieces fit together.

Your symptoms tell a story. The right testing helps us understand it.

Comprehensive Blood Work

Go beyond the basic annual panel with a more detailed look at metabolic, nutritional, thyroid, cardiovascular and other important health markers.

Some of the cardiovascular markers I commonly consider include:

ApoB — helps estimate the number of circulating atherogenic lipoprotein particles.

Lipoprotein(a) / Lp(a) — a largely genetically determined cardiovascular risk factor.

Standard lipid panel — total cholesterol, LDL-C, HDL-C, triglycerides and non-HDL-C.

hs-CRP — provides information about systemic inflammation relevant to cardiovascular risk.

Fasting glucose + fasting insulin + HbA1c — helps provide a broader look at glucose regulation and metabolic health.

Don’t just ask, “Is my cholesterol normal?” Ask what your numbers are actually telling you.

References

1. Matthews KA, Crawford SL, Chae CU, et al. “Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?” Journal of the American College of Cardiology. 2009;54(25):2366–2373. doi:10.1016/j.jacc.2009.10.009.
2. Matthews KA, et al. “Lipid Changes Around the Final Menstrual Period Predict Carotid Subclinical Disease in Postmenopausal Women.” Stroke. 2017;48(1):70–76. doi:10.1161/STROKEAHA.116.014743.
3. Walsh BW, Schiff I, Rosner B, et al. “Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins.” New England Journal of Medicine. 1991;325(17):1196–1204. doi:10.1056/NEJM199110243251702.
4. Sniderman AD, Thanassoulis G, Glavinovic T, et al. “Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.” JAMA Cardiology. 2019;4(12):1287–1295. doi:10.1001/jamacardio.2019.3780.
5. Reyes-Soffer G, et al. “Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease.” Arteriosclerosis, Thrombosis, and Vascular Biology. 2022;42(1):e48–e60. doi:10.1161/ATV.0000000000000147.